Okay.
Actually, Mr. Van Bynen, I applaud the investment that the Canadian government has made recently in the sector. My point today is that the ecosystem is much larger than just drug prices. It's about much more than that. We don't have a Canadian life sciences strategy right now. It does not exist. I think we should have one. We should take the opportunity that the pandemic is giving us, and the rebound that the economy should take, to actually think about putting in place a Canadian life sciences strategy that will take into consideration drug prices but also much more than just that.